5 months ago
SRPT
AnalystsMitchell KapoorMitchell Kapoor's Stock Forecasts
AnalystsMitchell Kapoor
Sectors:
Industries:
Analyst Ranking
Bottom 1%
#4864 out of 4868 analysts
Average Return
-18.88%
Win Rate
31%90 out of 288
Risk vs Reward
Poor
Good
Mitchell Kapoor's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Instil Bio IncTIL | +363.14% | $6.81 | $31.54 | 2023-11-13 - 2024-11-13 | Buy |
Summit Therapeutics IncSMMT | +119.67% | $10.98 | $24.12 | 2024-08-11 - 2025-04-30 | Buy |
Summit Therapeutics IncSMMT | +116.91% | $11.12 | $24.12 | 2024-08-13 - 2025-04-30 | Buy |
Lexeo Therapeutics IncLXEO | +115.93% | $1.82 | $3.93 | 2025-04-07 - 2025-04-30 | Buy |
Summit Therapeutics IncSMMT | +103.20% | $11.87 | $24.12 | 2024-08-14 - 2025-04-30 | Buy |
Mitchell Kapoor Analyst Color
Get additional color on Mitchell Kapoor's coverage of popular stocks
5 months ago
SRPT
7 months ago
SMMT
Mitchell Kapoor's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Alumis IncALMS | 12 | Buy | $14.00 | +238.16% | Reiterates | a day ago |
Editas Medicine IncEDIT | 1 | Buy | $3.00 | +81.82% | Initiates Coverage On | 3 days ago |
Halozyme Therapeutics IncHALO | 34 | Buy | $72.00 | +17.23% | Reiterates | 6 days ago |
Legend Biotech CorpLEGN | 37 | Buy | $75.00 | +114.59% | Reiterates | 15 days ago |
Sarepta Therapeutics IncSRPT | 11 | Hold | $75.00 | +20.19% | Reiterates | 15 days ago |
Lyell Immunopharma IncLYEL | 12 | Hold | $1.00 | +110.53% | Reiterates | 15 days ago |
Verve Therapeutics IncVERV | 6 | Buy | $25.00 | +340.92% | Maintains | 17 days ago |
Cartesian Therapeutics IncRNAC | 16 | Buy | $40.00 | +233.33% | Reiterates | 22 days ago |
Lexeo Therapeutics IncLXEO | 7 | Buy | $23.00 | +485.24% | Reiterates | 23 days ago |
Ionis Pharmaceuticals IncIONS | 1 | Buy | $45.00 | +46.53% | Initiates Coverage On | 24 days ago |
Kyverna Therapeutics IncKYTX | 6 | Hold | $4.00 | +73.16% | Maintains | a month ago |
Metagenomi IncMGX | 9 | Buy | $7.00 | +304.62% | Maintains | a month ago |
Zura Bio LtdZURA | 6 | Hold | $3.00 | +94.81% | Maintains | a month ago |
Rani Therapeutics Holdings IncRANI | 15 | Buy | $9.00 | +710.81% | Reiterates | a month ago |
Century Therapeutics IncIPSC | 16 | Buy | $2.00 | +269.00% | Maintains | a month ago |
Tyra Biosciences IncTYRA | 19 | Buy | $30.00 | +191.26% | Reiterates | a month ago |
Neurogene IncNGNE | 14 | Buy | $50.00 | +233.33% | Maintains | a month ago |
Abeona Therapeutics IncABEO | 2 | Buy | $15.00 | +128.66% | Reiterates | a month ago |
Korro Bio IncKRRO | 11 | Buy | $115.00 | +547.89% | Reiterates | a month ago |
Rallybio CorpRLYB | 19 | Buy | $5.00 | +1,462.50% | Reiterates | a month ago |
Instil Bio IncTIL | 13 | Buy | $110.00 | +756.03% | Reiterates | 2 months ago |
Intellia Therapeutics IncNTLA | 1 | Buy | $30.00 | +238.22% | Initiates Coverage On | 2 months ago |
Summit Therapeutics IncSMMT | 13 | Buy | $44.00 | +82.42% | Reiterates | 2 months ago |
Crispr Therapeutics AgCRSP | 2 | Buy | $65.00 | +68.09% | Reiterates | 3 months ago |
Oruka Therapeutics IncORKA | 5 | Buy | $45.00 | +331.03% | Reiterates | 3 months ago |
Tc Biopharm PLCTCBP | 3 | Buy | $48.00 | +9,500.00% | Maintains | 5 months ago |
Carisma Therapeutics IncCARM | 11 | Buy | $5.00 | +2,412.56% | Maintains | 5 months ago |
Onkure Therapeutics IncOKUR | 4 | Hold | $15.00 | +502.41% | Reiterates | a year ago |
Rain Oncology IncRAIN2 | 2 | Buy | $19.00 | N/A | Maintains | 2 years ago |
Imago Biosciences IncIMGO | 4 | Hold | $36.00 | N/A | Downgrades | 2 years ago |
Aditxt IncADTX | 1 | Buy | $1,600,000.00 | N/A | Initiates Coverage On | 2 years ago |
Cytomx Therapeutics IncCTMX | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.